Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270
Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/
On-demand Clinical Care Options (CCO) Webcast on corneal toxicity in patients receiving antibody-drug conjugate therapy for the treatment of cancer
Downloadable slides with notes from pharmacist and nursing experts on maintenance avelumab, enfortumab vedotin and erdafitinib for urothelial carcinoma, from CCO
Simplified treatment option resource for advanced urothelial carcinoma highlighting recently approved agents, from Clinical Care Options (CCO)
CCO guide on signs and symptoms of potential AEs for your patients receiving erdafitinib or enfortumab vedotin
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.